Search company, investor...

Scion Pharmaceuticals

Founded Year

2001

Stage

Series B | Alive

Total Raised

$24.3M

Last Raised

$17.5M | 21 yrs ago

About Scion Pharmaceuticals

Scion Pharmaceuticals is a Healthcare/Pharmaceuticals / Drugs company based in Medford, Massachusetts. Scion Pharmaceuticals' investors include GeneChem Management, Life Sciences Partners, Neuroventures Capital, Gray Ghost Ventures, Oxford Bioscience Partners, Lancet Capital, SR One and Lehman Brothers.

Headquarters Location

200 Boston Avenue Suite 3600

Medford, Massachusetts, 02155,

United States

781-391-1900

Missing: Scion Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Scion Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Scion Pharmaceuticals Patents

Scion Pharmaceuticals has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/7/2006

10/18/2011

Ion channels, Calcium channel blockers, Integral membrane proteins, Electrophysiology, Membrane biology

Grant

Application Date

2/7/2006

Grant Date

10/18/2011

Title

Related Topics

Ion channels, Calcium channel blockers, Integral membrane proteins, Electrophysiology, Membrane biology

Status

Grant

Scion Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Scion Pharmaceuticals founded?

    Scion Pharmaceuticals was founded in 2001.

  • Where is Scion Pharmaceuticals's headquarters?

    Scion Pharmaceuticals's headquarters is located at 200 Boston Avenue, Medford.

  • What is Scion Pharmaceuticals's latest funding round?

    Scion Pharmaceuticals's latest funding round is Series B.

  • How much did Scion Pharmaceuticals raise?

    Scion Pharmaceuticals raised a total of $24.3M.

  • Who are the investors of Scion Pharmaceuticals?

    Investors of Scion Pharmaceuticals include Oxford Bioscience Partners, Neuroventures Capital, EQT Life Sciences, GeneChem Management, SR One and 5 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.